289 related articles for article (PubMed ID: 33844308)
21. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.
Beck LA; Boguniewicz M; Hata T; Schneider LC; Hanifin J; Gallo R; Paller AS; Lieff S; Reese J; Zaccaro D; Milgrom H; Barnes KC; Leung DY
J Allergy Clin Immunol; 2009 Aug; 124(2):260-9, 269.e1-7. PubMed ID: 19541356
[TBL] [Abstract][Full Text] [Related]
22. Cathelicidin deficiency predisposes to eczema herpeticum.
Howell MD; Wollenberg A; Gallo RL; Flaig M; Streib JE; Wong C; Pavicic T; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2006 Apr; 117(4):836-41. PubMed ID: 16630942
[TBL] [Abstract][Full Text] [Related]
23. Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections.
Berdyshev E; Goleva E; Bronova I; Bronoff AS; Streib JE; Vang KA; Richers BN; Taylor P; Beck L; Villarreal M; Johnson K; David G; Slifka MK; Hanifin J; Leung DYM
J Allergy Clin Immunol; 2022 Sep; 150(3):640-648. PubMed ID: 35304160
[TBL] [Abstract][Full Text] [Related]
24. IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.
Kim BE; Bin L; Ye YM; Ramamoorthy P; Leung DYM
J Invest Dermatol; 2013 Dec; 133(12):2678-2685. PubMed ID: 23657503
[TBL] [Abstract][Full Text] [Related]
25. Eczema herpeticum in children with atopic dermatitis.
Lai YC; Shyur SD; Fu JL
Acta Paediatr Taiwan; 1999; 40(5):325-9. PubMed ID: 10910542
[TBL] [Abstract][Full Text] [Related]
26. Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum.
Staudacher A; Hinz T; Novak N; von Bubnoff D; Bieber T
Allergy; 2015 Nov; 70(11):1432-9. PubMed ID: 26198597
[TBL] [Abstract][Full Text] [Related]
27. The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.
Howell MD; Gao P; Kim BE; Lesley LJ; Streib JE; Taylor PA; Zaccaro DJ; Boguniewicz M; Beck LA; Hanifin JM; Schneider LC; Hata TR; Gallo RL; Kaplan MH; Barnes KC; Leung DY
J Allergy Clin Immunol; 2011 Nov; 128(5):1006-14. PubMed ID: 21762972
[TBL] [Abstract][Full Text] [Related]
28. Systemic herpes simplex virus infection in a child with eczema herpeticum.
Akamatsu M; Kawamura Y; Miura H; Sugimoto E; Okamoto K; Nakajima Y; Kozawa K; Furukawa G; Tanaka M; Kudo K; Yoshikawa T
Pediatr Dermatol; 2023; 40(3):582-583. PubMed ID: 36682743
[TBL] [Abstract][Full Text] [Related]
29. Defective natural killer cell activity in a mouse model of eczema herpeticum.
Kawakami Y; Ando T; Lee JR; Kim G; Kawakami Y; Nakasaki T; Nakasaki M; Matsumoto K; Choi YS; Kawakami T
J Allergy Clin Immunol; 2017 Mar; 139(3):997-1006.e10. PubMed ID: 27476888
[TBL] [Abstract][Full Text] [Related]
30. Infectious Complications in Atopic Dermatitis.
Sun D; Ong PY
Immunol Allergy Clin North Am; 2017 Feb; 37(1):75-93. PubMed ID: 27886912
[TBL] [Abstract][Full Text] [Related]
31. Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review.
Ong PY; Leung DY
Clin Rev Allergy Immunol; 2016 Dec; 51(3):329-337. PubMed ID: 27377298
[TBL] [Abstract][Full Text] [Related]
32. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.
Wollenberg A; Zoch C; Wetzel S; Plewig G; Przybilla B
J Am Acad Dermatol; 2003 Aug; 49(2):198-205. PubMed ID: 12894065
[TBL] [Abstract][Full Text] [Related]
33. History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis.
Moran MC; Klose A; Yoshida T; De Benedetto A; Schneider LC; Ong PY; Simpson EL; Leung DYM; Miller BL; Seplaki CL; Beck LA
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2417-2429. PubMed ID: 37615834
[TBL] [Abstract][Full Text] [Related]
34. Replicated methylation changes associated with eczema herpeticum and allergic response.
Boorgula MP; Taub MA; Rafaels N; Daya M; Campbell M; Chavan S; Shetty A; Cheadle C; Barkataki S; Fan J; David G; Beaty TH; Ruczinski I; Hanifin J; Schneider LC; Gallo RL; Paller AS; Beck LA; Leung DY; Mathias RA; Barnes KC
Clin Epigenetics; 2019 Aug; 11(1):122. PubMed ID: 31443688
[TBL] [Abstract][Full Text] [Related]
35. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-γ-producing CD8+ T cells.
Mathias RA; Weinberg A; Boguniewicz M; Zaccaro DJ; Armstrong B; Schneider LC; Hata TR; Hanifin JM; Beck LA; Barnes KC; Leung DY
Br J Dermatol; 2013 Sep; 169(3):700-3. PubMed ID: 23600999
[TBL] [Abstract][Full Text] [Related]
36. Not all that vesicles is herpes.
Gruhl RR; Wu A; Niermann M; Olson A
Diagnosis (Berl); 2017 Nov; 4(4):261-264. PubMed ID: 29536938
[TBL] [Abstract][Full Text] [Related]
37. [Eczema herpeticum in a patient with atopic dermatitis, carrying r501x and 2282del4 filaggrin null mutations].
Valdés-Rodríguez R; Saavedra-Alanís VM; Islas-Aguilar MA; Torres-Álvarez B
Gac Med Mex; 2015; 151(2):252-5. PubMed ID: 25946536
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.
Gao PS; Leung DY; Rafaels NM; Boguniewicz M; Hand T; Gao L; Hata TR; Schneider LC; Hanifin JM; Beaty TH; Beck LA; Weinberg A; Barnes KC
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):650-7. PubMed ID: 22113474
[TBL] [Abstract][Full Text] [Related]
39. Characterization of children with recurrent eczema herpeticum and response to treatment with interferon-gamma.
Darji K; Frisch S; Adjei Boakye E; Siegfried E
Pediatr Dermatol; 2017 Nov; 34(6):686-689. PubMed ID: 29144049
[TBL] [Abstract][Full Text] [Related]
40. Innate immunity in atopic dermatitis.
Wollenberg A; Räwer HC; Schauber J
Clin Rev Allergy Immunol; 2011 Dec; 41(3):272-81. PubMed ID: 21181301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
